Advertisement

Topics

Latest "Precision Optics" News Stories

01:21 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "Precision Optics" found in our extensive news archives from over 250 global news sources.

More Information about Precision Optics on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Precision Optics for you to read. Along with our medical data and news we also list Precision Optics Clinical Trials, which are updated daily. BioPortfolio also has a large database of Precision Optics Companies for you to search.

Showing "Precision Optics" News Articles 1–25 of 3,000+

Tuesday 18th September 2018

3-Year Clinical Outcomes and BPH Subgroup Analysis of Profound Medical’s Phase I Clinical Trial to be Included in Presentation at DGU 2018

TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) — Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time Magnetic Resonance (“MR”) imaging combined with the safety and ablation … Continue reading → Cet article 3-Year Clinical Outcomes and BPH Subgroup Analysis o...


Jackson Memorial Hospital Installs Canon Medical Systems’ Aquilion ONE / GENESIS Edition to Improve Patient Care and Competitive Advantage

Innovative CT Technology Enables the Hospital to Expand Services to More Patients and Increase Exam Volume Clinicians at Jackson Memorial Hospital now have access to the latest in dynamic volume CT technology with the installation of the Aquilion™ ONE / GENESIS Edition from

Continuum Clinical Names Kevin Hartbarger as New VP, Media

Global patient recruitment and retention company, Continuum Clinical is proud to announce Kevin Hartbarger as its new vice president of media. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180918005943/en/


Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, and NovellusDx, a leader in functional genomics, today announced the signing of a definitive agreement under which NovellusDx will merge with a newly formed Israeli subsidiary of Cancer Genetics and shareholders of NovellusDx will receive stock ...

Science has helped advance our understanding of #severeasthma, but it may remain uncontrolled. We're committed to redefining how severe #asthma is managed. To achieve this, we've embarked on a program called PRECISION. Dr. Lykke shares more: http://bit.l

Science has helped advance our understanding of #severeasthma, but it may remain uncontrolled. We're committed to redefining how severe #asthma is managed. To achieve this, we've embarked on a program called PRECISION. Dr. Lykke shares more: http://bit.ly/2NHByo0 . #ERSCongress pic.twitter.com/OPIbyZRGFl

National Integrated Health Associates Welcomes Sherif Hassan, MD, to the Functional Medicine Team

National Integrated Health Associates (NIHA), a leading integrative medical and dental center in Washington, D.C., is pleased to announce Dr. Sherif Hassan has joined the medical team. WASHINGTON (PRWEB) September 18, 2018 Dr. Sherif Hassan is an internal medicine physician with broad international experience. Trained in the United Kingdom as a Critical Care Physician, he has worked in several Un...

Quanterix CEO Leads Webinar on How Digital Biomarkers are Empowering Drug Development

Top researchers join the discussion on biomarker innovations for accelerating drug development Brief Quanterix business update to be provided as well Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced Chairman and Chief Executive Office...

Thermal Ablation Effectively Treats Early-stage Lung Cancer

Thermal ablation is a safe, effective treatment for early-stage lung cancer, according to a study published in the journal Radiology. The results show that ablation may be an effective alternative for patients who cannot undergo lung cancer surgery because of age or health status. OAK BROOK, Ill. (PRWEB) September 18, 2018 Thermal ablation is a safe, effective treatment for early-stage lung cance...

Freudenberg Medical Presents New Catheter Handle Platform and Steerable Introducer Products at Transcatheter Cardiovascular Therapeutics 2018

Innovative Device and Design Solutions for Accelerating Time to Market Freudenberg Medical, a global developer and manufacturer of finished medical devices and subassemblies, components, and minimally invasive solutions for the medical device industry, announced several new options for medical device companies looking to accelerate time to marke...

Nanomedical Diagnostics CTO Brett Goldsmith to Speak at David Myszka’s SensorCon 2018 Conference

Dr. Goldsmith will share experiments showcasing characterization of MYC oncoprotein, Zika virus, G-protein-coupled receptors, and aptamers with Agile R100, a versatile Field Effect Biosensing system. SAN DIEGO (PRWEB) September 18, 2018 At the end of September, representatives from top biosensor companies will converge on Salt Lake City, UT to take part in Dr. David Myszka’s SensorCon conferenc...

Precision Medicine Comes of Age

After years of research, therapies tailored to the genomes of individual patients are reaching maturity -- Read more on ScientificAmerican.com

Visioneering Announces First International Revenues and Attendance at Myopia Conference in Australia

Recently Signed Australian Optometrists Report Rapid Patient Success With NaturalVue® Multifocal 1 Day Contact Lenses Normally, one could expect a lag between accounts signing up and revenue starting from those accounts, but shortly after signing Visioneering Technologies’, Inc. (ASX: VTI) first international eye care practitioners in Australia, the...

Monday 17th September 2018

Precision Medical Solutions® Debuts Leading-Edge Adult Circumcision Technique in Denver

Dr. Briana Oster is proud to be the first Shang-Ring certified doctor in the western United States! Circumcision has long been encouraged by doctors and scientists for a reduced risk of disease, cancer, and sexually-transmitted diseases including HIV/AIDs. As adults, many men also elect circumcision for cosmetic reasons, hygienic reasons, or to treat m...

Rigaku Innovative Technologies Presents High Performance Thin Film Coatings and Optics at SPIE Photomask Technology + EUV Lithography 2018

Rigaku Innovative Technologies is presenting its multilayer optics for EUV lithography at the SPIE Photomask Technology + EUV Lithography 2018 meeting in Monterey, California MONTEREY, Calif. (PRWEB) September 17, 2018 Rigaku Innovative Technologies (RIT), a leading global supplier of multilayer optics for EUV lithography (EUVL), is pleased to announce its attendance at the SPIE Photomask Technol...

Navidea Biopharmaceuticals Announces Acceptance into the National Institutes of Health Commercialization Accelerator Program

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today acceptance into the National Institutes of Health (“NIH”) Commercialization Accelerator Program (“CAP”) 2018-2019. The Company was sel...

Navidea Biopharmaceuticals Announces Closing of a $3 Million Private Placement

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today closing of a $3 million private placement. The Company entered into a definitive securities purchase agreement with an existing investor, John K. Scott, ...

Corindus to Present at Ladenburg Thalmann 2018 Healthcare Conference

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, will present at the Ladenburg Thalmann 2018 Healthcare Conference as follows:       ...

Faron Pharma submits clinical trial application for its precision cancer immunotherapy

It paves the way for a Phase I/II study, called MATINS, that will assess the safety and efficacy of the drug candidate

MEDTEX: Foresee the Next Wave of Healthcare Revolution

From AIoT, Blockchain, Gene Editing, Cell Therapy, to Immune-Oncology, Med x Tech Summit Asia (MEDTEX) brings over 30 cross-industry global key opinion leaders to Taipei. Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in global healthcare technology and provider. On November 29 - 30, MEDTEX will...

Geneus Health Granted Rare Groundbreaking Genetic Patent

GARS™ is the product of over 30 years of intense research and extensive analysis of the genetic link to addiction, performed by preeminent scientist Dr. Kenneth Blum. SAN ANTONIO, Texas (PRWEB) September 17, 2018 Geneus Health announced last week that after years of intensive review, they’ve completed the final process and have been issued a patent by the U.S. Patent Office, with an unprecede...

Congenica Announces Market Access Partnership with Digital China Health to Enable Genomic Medicine in the Chinese Market

Partnership will accelerate Congenica’s commercial expansion in the Chinese market Digital China Health is a key player in China’s national big-data strategy, with a strategic mission to advance health information technology Locally-adapted version of the Sapientia™ platform will enable genomic me...

OV - Updated LiPlaCis data positions LiPlaCis and its DRP for an FDA Breakthrough Therapy designation application for breast cancer

Hoersholm, Denmark, September 17, 2018 - Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) ("OV" or "the Company") announce the fourth update from the ongoing LiPlaCis® Phase 2 study. In the ongoing study, the data points to the possibility of obtaining a Breakthrough Therapy designation by the FDA. In the LiPlaCis DRP top tier group (1/3) of highest l...

London biotherapeutics powerhouse launched by Cancer Research UK

Press release The city of London will be transformed into a world leading hub for cancer biotherapeutics research and treatment, with a new £14 million investment from Cancer Research UK, announced today. “The unique research focus of the Cancer Research UK City of London Centre will lay the foundation for the future of precision medicine.”- Dr Iain Foulkes The new Cancer Research UK City...

Packline Materials Handling Announce Production Of The New Single Spindle Attachment With Rollers, For Handling Heavy Rolls Of Film And Foil

New from Packline, the bespoke single spindle attachment with fitted rollers is designed to lift and handle heavy rolls of film and paper. Constructed mainly from stainless steel, the roll handling equipment is suitable for clean room and high care environments, such as food and pharmaceutical industries. KANSAS CITY, Mo. (PRWEB) September 17, 2018 New from Packline, the bespoke single spindle at...

Faron Pharma submits clinical trial application for its its precision cancer immunotherapy

It paves the way for a phase I/II study, called MATINS, that will assess the investigate safety and efficacy of the drug candidate


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks